X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1319) 1319
Paper (581) 581
Publication (452) 452
Report (86) 86
Book / eBook (26) 26
Conference Proceeding (12) 12
Data Set (8) 8
Newspaper Article (7) 7
Patent (7) 7
Book Chapter (4) 4
Magazine Article (4) 4
Book Review (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (649) 649
particle physics (573) 573
physics (566) 566
high energy physics - experiment (547) 547
physics - high energy physics - experiment (512) 512
high energy physics (416) 416
phenomenology (251) 251
cern lhc coll (242) 242
experimental results (234) 234
index medicus (215) 215
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (213) 213
humans (211) 211
physical sciences (210) 210
physics of elementary particles and fields (210) 210
fysik (209) 209
nuclear experiment (188) 188
natural sciences (186) 186
naturvetenskap (186) 186
particle physics - experiment (160) 160
scattering [p p] (141) 141
hematology (140) 140
female (118) 118
male (118) 118
colliding beams [p p] (117) 117
aged (116) 116
8000 gev-cms (112) 112
multiple myeloma (110) 110
subatomär fysik (107) 107
subatomic physics (106) 106
hadron-hadron scattering (102) 102
middle aged (99) 99
p p: scattering (99) 99
physics, particles & fields (93) 93
multiple myeloma - drug therapy (92) 92
atlas (91) 91
p p: colliding beams (90) 90
bortezomib (88) 88
elementary particles, quantum field theory (85) 85
quantum field theories, string theory (85) 85
astrophysics (82) 82
13000 gev-cms (77) 77
high energy astrophysical phenomena (76) 76
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (75) 75
science & technology (75) 75
ciências físicas [ciências naturais] (71) 71
oncology (71) 71
antineoplastic combined chemotherapy protocols - therapeutic use (69) 69
hep (62) 62
adult (60) 60
collisions (59) 59
detectors (59) 59
ex (59) 59
aged, 80 and over (58) 58
astronomy, astrophysics and cosmology (57) 57
survival (56) 56
large hadron collider (53) 53
measurement science and instrumentation (52) 52
prognosis (52) 52
stem-cell transplantation (52) 52
nuclear physics, heavy ions, hadrons (51) 51
background (50) 50
dexamethasone (48) 48
multiple myeloma - mortality (48) 48
nuclear energy (46) 46
risk factors (46) 46
treatment outcome (46) 46
multiple myeloma - pathology (45) 45
physics and astronomy (45) 45
analysis (44) 44
engineering (44) 44
abridged index medicus (43) 43
multiple myeloma - therapy (43) 43
física (41) 41
antineoplastic combined chemotherapy protocols - adverse effects (40) 40
nuclear and high energy physics (40) 40
therapy (40) 40
transverse momentum dependence (40) 40
lenalidomide (39) 39
物理学 (39) 39
settore fis/01 - fisica sperimentale (38) 38
multiple myeloma - diagnosis (37) 37
parton distributions (37) 37
supersymmetry (37) 37
data analysis method (36) 36
instrumentation and detectors (36) 36
care and treatment (35) 35
thalidomide - analogs & derivatives (35) 35
classical and quantum gravitation, relativity theory (34) 34
mass dependence (34) 34
quantum physics (34) 34
settore fis/04 - fisica nucleare e subnucleare (33) 33
astronomy & astrophysics (32) 32
rapidity dependence (32) 32
multiple myeloma - genetics (31) 31
spain (31) 31
thalidomide (31) 31
cern lab (30) 30
missing-energy [transverse momentum] (30) 30
kinematics (29) 29
disease progression (28) 28
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 09/2018, Volume 13, Issue 9, p. e0203392
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4739 - 4739
Introduction: For patients with newly diagnosed multiple myeloma (NDMM) who are transplant-eligible, bortezomib/thalidomide/dexamethasone (VTd) is a standard... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3553 - 3553
Abstract Introduction: For transplant-ineligible patients (pts) with newly diagnosed MM, the efficacy of VMP was established in the phase 3 VISTA trial. To... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1963 - 1963
Abstract Introduction: Continuous treatment with lenalidomide (len) is a new standard of care in frontline multiple myeloma (MM) (Facon. Blood.... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2321 - 2321
Abstract Background Lenalidomide in combination to steroid therapy, including high-dose dexamethasone (RD), low-dose dexamethasone (Rd) or triple therapy of... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2015, Volume 90, Issue 8, p. 146
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1964 - 1964
Abstract Introduction: Carfilzomib is an irreversible proteasome inhibitor with proven efficacy as a single agent and in doublet and triplet combinations... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3550 - 3550
Abstract Introduction: VMP is a standard of care regimen for transplant-ineligible NDMM outside of the United States. The VISTA trial established the dosing... 
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e31 - e32
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e266 - e267
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2019, Volume 19, pp. S320 - S321
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 23 - 23
Abstract Introduction: Massive parallel sequencing of tumor cells obtained from the bone marrow (BM) of patients with multiple myeloma (MM) has demonstrated... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.